{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:38:57Z","timestamp":1761863937625,"version":"3.37.3"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Foundation of South China University of Technology","award":["x2yxD2182200"],"award-info":[{"award-number":["x2yxD2182200"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030310388"],"award-info":[{"award-number":["2018A030310388"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Medical Science Foundation","award":["A2018363"],"award-info":[{"award-number":["A2018363"]}]},{"name":"Municipal Science and Technology Program of Shenzhen","award":["JCYJ20150630164505510"],"award-info":[{"award-number":["JCYJ20150630164505510"]}]},{"name":"Open Project Program of the State Key Laboratory of Proteomics","award":["SKLP-O201506"],"award-info":[{"award-number":["SKLP-O201506"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejphar.2019.02.021","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T23:17:34Z","timestamp":1550099854000},"page":"167-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis"],"prefix":"10.1016","volume":"850","author":[{"given":"Yan-hong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-xiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.02.021_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ibd.20652","article-title":"Applications of proteomics in the study of inflammatory bowel diseases: current status and future directions with available technologies","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2019.02.021_bib2","first-page":"71","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.phytochem.2017.12.023","article-title":"An OMIC approach to elaborate the antibacterial mechanisms of different alkaloids","volume":"149","author":"Avci","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejphar.2019.02.021_bib4","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.3748\/wjg.v20.i12.3231","article-title":"Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies","volume":"20","author":"Bennike","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib5","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/MIB.0000000000000460","article-title":"Neutrophil extracellular traps in ulcerative colitis: a proteome analysis of intestinal biopsies","volume":"21","author":"Bennike","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2019.02.021_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1568-9972(01)00018-0","article-title":"High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?","volume":"1","author":"Burger","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejphar.2019.02.021_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpba.2015.04.013","article-title":"Stable isotope labelling methods in mass spectrometry-based quantitative proteomics","volume":"113","author":"Chahrour","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2019.02.021_bib8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00216-012-6012-9","article-title":"Isobaric tagging approaches in quantitative proteomics: the ups and downs","volume":"404","author":"Christoforou","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejphar.2019.02.021_bib9","doi-asserted-by":"crossref","first-page":"e78128","DOI":"10.1371\/journal.pone.0078128","article-title":"M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis","volume":"8","author":"Cosin-Roger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.02.021_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fphar.2018.00571","article-title":"Berberine regulates Treg\/Th17 balance to treat ulcerative colitis through modulating the gut microbiota in the colon","volume":"9","author":"Cui","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.drudis.2010.10.002","article-title":"Pharmacoproteomics: a chess game on a protein field","volume":"15","author":"D'Alessandro","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2019.02.021_bib12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/pmic.201100463","article-title":"Using iRT, a normalized retention time for more targeted measurement of peptides","volume":"12","author":"Escher","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.ejphar.2019.02.021_bib13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/MIB.0000000000000394","article-title":"Lipidomic profiling in inflammatory bowel disease: comparison between ulcerative colitis and crohn's disease","volume":"21","author":"Fan","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2019.02.021_bib14","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/MCB.23.13.4559-4572.2003","article-title":"H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo","volume":"23","author":"Fan","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib15","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/onc.2015.307","article-title":"Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis","volume":"35","author":"Gkouskou","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2019.02.021_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MPG.0b013e3181c15f43","article-title":"Proteomic analysis of biopsied human colonic mucosa","volume":"51","author":"Gourley","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ejphar.2019.02.021_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.phrs.2016.09.041","article-title":"Berberine and inflammatory bowel disease: a concise review","volume":"113","author":"Habtemariam","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2019.02.021_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00535-009-0183-y","article-title":"Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease","volume":"45","author":"Hatsugai","year":"2010","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.peptides.2003.07.028","article-title":"Antimicrobial polypeptides of the human colonic epithelium","volume":"24","author":"Howell","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2019.02.021_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-011-0325-6","article-title":"PI3K\/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis","volume":"60","author":"Huang","year":"2011","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2019.02.021_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/omi.2013.0100","article-title":"Assessment of berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning","volume":"18","author":"Karaosmanoglu","year":"2014","journal-title":"OMICS"},{"key":"10.1016\/j.ejphar.2019.02.021_bib22","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s003840100311","article-title":"Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats","volume":"16","author":"Kullmann","year":"2001","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.ejphar.2019.02.021_bib24","doi-asserted-by":"crossref","first-page":"e32084","DOI":"10.1371\/journal.pone.0032084","article-title":"Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon","volume":"7","author":"Laroui","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.02.021_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2010.08.046","article-title":"Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-kappab activation","volume":"648","author":"Lee","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.molimm.2015.07.013","article-title":"Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1\/Th17 differentiation","volume":"67","author":"Li","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.phrs.2016.02.010","article-title":"Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL\/6 mice by suppressing Th17 responses","volume":"110","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2019.02.021_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.fct.2016.08.031","article-title":"Pre-clinical toxicity of a combination of berberine and 5-aminosalicylic acid in mice","volume":"97","author":"Li","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib29","doi-asserted-by":"crossref","first-page":"e0144101","DOI":"10.1371\/journal.pone.0144101","article-title":"Addition of berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL\/6 mice","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.02.021_bib30","first-page":"1341","article-title":"Animal models of ulcerative colitis and their application in drug research","volume":"7","author":"Low","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2019.02.021_bib31","doi-asserted-by":"crossref","first-page":"G878","DOI":"10.1152\/ajpgi.00400.2009","article-title":"The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease","volume":"298","author":"Lu","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib32","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2019.02.021_bib33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib34","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s10620-017-4673-0","article-title":"Proteomics in inflammatory bowel disease: approach using animal models","volume":"62","author":"Mourad","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2019.02.021_bib35","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.crohns.2014.03.006","article-title":"The incidence of ulcerative colitis (1995\u20132011) and Crohn's disease (1995\u20132012) - based on nationwide Danish registry data","volume":"8","author":"Norgard","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ejphar.2019.02.021_bib36","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1111\/bph.13556","article-title":"The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration","volume":"173","author":"Nowacki","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2019.02.021_bib37","doi-asserted-by":"crossref","first-page":"S560","DOI":"10.1093\/ecco-jcc\/jjw115","article-title":"Discovery of biomarkers of response in early drug development","volume":"10","author":"O'Byrne","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ejphar.2019.02.021_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-230X-12-76","article-title":"Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis","volume":"12","author":"Poulsen","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.0903853","article-title":"Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine","volume":"185","author":"Qin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/ibd.21212","article-title":"New proteomic approaches for biomarker discovery in inflammatory bowel disease","volume":"16","author":"Roda","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2019.02.021_bib41","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.crohns.2014.01.025","article-title":"Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)","volume":"8","author":"Salaga","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.ejphar.2019.02.021_bib42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of crohn's disease and ulcerative colitis in olmsted county, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib43","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.crohns.2013.02.006","article-title":"Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005\u20132009 - results from the IBD cohort of the Uppsala Region (ICURE)","volume":"7","author":"Sjoberg","year":"2013","journal-title":"J. Crohns Colitis"},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2019.02.021_bib44","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/MCG.0000000000000253","article-title":"Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity","volume":"48","author":"Speca","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092775","article-title":"Proteomics and lipidomics in inflammatory bowel disease research: from mechanistic insights to biomarker identification","volume":"19","author":"Titz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.02.021_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0196-9781(03)00114-1","article-title":"Antimicrobial peptides in the first line defence of human colon mucosa","volume":"24","author":"Tollin","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2019.02.021_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1586\/epr.10.29","article-title":"Isobaric protein and peptide quantification: perspectives and issues","volume":"7","author":"Treumann","year":"2010","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.ejphar.2019.02.021_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.plefa.2014.09.003","article-title":"Partial replacement of dietary linoleic acid with long chain n-3 polyunsaturated fatty acids protects against dextran sulfate sodium-induced colitis in rats","volume":"91","author":"Tyagi","year":"2014","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ejphar.2019.02.021_bib49","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.02.021_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jprot.2015.11.013","article-title":"Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model","volume":"132","author":"Wang","year":"2016","journal-title":"J. Proteom."},{"key":"10.1016\/j.ejphar.2019.02.021_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/pmic.201300393","article-title":"The OMSSAPercolator: an automated tool to validate OMSSA results","volume":"14","author":"Wen","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.ejphar.2019.02.021_bib52","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/pmic.201300361","article-title":"IQuant: an automated pipeline for quantitative proteomics based upon isobaric tags","volume":"14","author":"Wen","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.ejphar.2019.02.021_bib53","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/pmic.201500174","article-title":"Proteomic profiling of dextran sulfate sodium induced acute ulcerative colitis mice serum exosomes and their immunomodulatory impact on macrophages","volume":"16","author":"Wong","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.ejphar.2019.02.021_bib54","doi-asserted-by":"crossref","first-page":"G504","DOI":"10.1152\/ajpgi.00312.2011","article-title":"Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice","volume":"302","author":"Yan","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2019.02.021_bib55","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3892\/etm.2017.4402","article-title":"Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress","volume":"13","author":"Zhang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2019.02.021_bib56","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/pr100969w","article-title":"Evaluation of p38 MAPK pathway as a molecular signature in ulcerative colitis","volume":"10","author":"Zhao","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejphar.2019.02.021_bib57","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s13238-017-0413-7","article-title":"Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease","volume":"8","author":"Zheng","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejphar.2019.02.021_bib58","first-page":"822","article-title":"The effect of berberine chloride on experimental colitis in rats in vivo and in vitro","volume":"294","author":"Zhou","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.02.021_bib59","article-title":"Pharmacoproteomics profiling of plasma from beta-thalassemia patients in response to hydroxyurea treatment","author":"Zohaib","year":"2018","journal-title":"J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T14:44:32Z","timestamp":1565189072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919301141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":59,"alternative-id":["S0014299919301141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.021","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}